Pharmacovigilance newsletter No 15

An Adverse Event Following Immunization (AEFI) is any untoward medical occurrence which follows immunization and which does not necessarily have a causal relationship with the usage of the vaccine. The adverse event may be any unfavorable or unintended sign, abnormal laboratory finding, symptom or disease. Reported adverse events can either be a result of the…

Pharmacovigilance newsletter No 10

The importance of Adverse Drug Event Reporting (ADE) system lies in its objective which is ,the provision of drug safety data to FMHACA pharmacovigilance center .This initial information enriched by further investigation will finally enable the users to prevent the recurrence of the adverse drug event in other patients resulting in the delivery of a…

pharmacovigilance newsletter No 11

After I participated in the workshop on Pharmacovigilance which was organized by SIAPS/ USAID in collaboration with PFSA at Jimma some eight months back, I started to understand and visualize the magnitude of the problem and its importance as well. Thereafter, I became very interested and vowed to report ADE whenever I come across and…

pharmacovigilance newsletter no 7

Nigst Eleni Mohammed Memorial Hospital is situated in Hadiya zone at Hosanna town in the South Nations Nationalities and Peoples Republic. It is a known fact that drugs are important for disease prevention as well as curative purpose and hence saves life .But this indispensable remedy by its nature has unwanted adverse effect. Knowing this…

Pharmacovigilance newsletter 16

Importance of Active surveillance and Cohort Event monitoring on ARV medicines in Ethiopia The cornerstone of any pharmacovigilance system is Spontaneous reporting system which is a passive surveillance system that uses voluntary reporting of an adverse drug reaction by a health professional or a patient with the main objective being able to provide signals with…

Pharmacovigilance newsletter 14

Training was given to six health centers of yeka sub city on pharmacovigilance from January 22 to the end of March 2016. Wereda 8/Chefe Health center (HC), Wereda 12 HC, Entoto no 2 HC, and Ferensay Akababi HC. A total of 176 health providers were trained on the limitations of premarketing evaluations ,the importance of…

EFDA Directorates

Director General QMS Lead Executive Officer QMS Desk 1 QMS Desk 2 Intelligence & illegal Trade Prevention Lead Executive Officer Intelligence & illegal Trade Prevention Desk Regulatory Information Development & Dissemination Desk Branch Coordination Lead Executive Officer Branch Office Head Port of Entry and Exit Director General Office Ethics and Anti corruption Executive Officer Audit…